Please wait while the formulary information is being retrieved.
REDNESS RELIEF (NAPHAZOLINE HCL/GLYCERIN)
- Dry eye
- Ocular irritation
- Ocular redness
- Redness Reliever Lubricant Eye Drops
- Redness Relief Eye Drops
- Clear Eyes Redness Relief Drops
- Clear Eyes Maximum Redness Relief Drops
- Clear Eyes Cooling Comfort Drops
Redness Reliever Lubricant 0.012 %-0.2 % eye drops
- Dosage information is not available
0.012 %-0.2 % eye drops
- Dosage information is not available
0.012 %-0.25 % eye drops
- Dosage information is not available
0.03 %-0.5 % eye drops
- Dosage information is not available
Redness Relief 0.012 %-0.2 % eye drops
- Dosage information is not available
Redness Relief 0.012 %-0.25 % eye drops
- Dosage information is not available
Redness Relief 0.03 %-0.5 % eye drops
- Dosage information is not available
0.012 %-0.2 % drops
- Dosage information is not available
0.012 %-0.25 % drops
- Dosage information is not available
Clear Eyes Maximum Redness Relief 0.03 %-0.5 % drops
- Dosage information is not available
Clear Eyes Cooling Comfort 0.03 %-0.5 % drops
- Dosage information is not available
- None
Contraindicated
- None
Severe
Moderate
- None
- Angle-closure glaucoma
Contraindicated
- None
Severe
Moderate
- Diabetes mellitus
- Hypertension
- Hyperthyroidism
- Ocular infection
- Ocular injury
REDNESS RELIEF (NAPHAZOLINE HCL/GLYCERIN)
- Dry eye
- Ocular irritation
- Ocular redness
- None
- None
More Frequent
Severe
Less Severe
- None
- Blurred vision
- Mydriasis
- Ocular irritation
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Dizziness
- Hyperhidrosis
- Hypertension
- Ocular hypertension
- Punctate keratitis
Less Severe
- Drowsy
- General weakness
- Headache disorder
- Hyperglycemia
- Nausea
- Nervousness
- Photophobia
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Naphazoline (Ophth)
Risk of CNS depression. Consult clinician for use in children age < 6 years.
- 1 Day – 6 Years
- Risk of CNS depression. Consult clinician for use in children age < 6 years.
Naphazoline Hydrochloride
- Severity Level:
C
- Additional Notes: Insufficient data available
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Naphazoline Hydrochloride
Insufficient data available.
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available. |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Dry eye | |
| H04.12 | Dry eye syndrome |
| H04.121 | Dry eye syndrome of right lacrimal gland |
| H04.122 | Dry eye syndrome of left lacrimal gland |
| H04.123 | Dry eye syndrome of bilateral lacrimal glands |
| H04.129 | Dry eye syndrome of unspecified lacrimal gland |
| H11.14 | Conjunctival xerosis, unspecified |
| H11.141 | Conjunctival xerosis, unspecified, right eye |
| H11.142 | Conjunctival xerosis, unspecified, left eye |
| H11.143 | Conjunctival xerosis, unspecified, bilateral |
| H11.149 | Conjunctival xerosis, unspecified, unspecified eye |
| H16.221 | Keratoconjunctivitis sicca, not specified as sjogren's, right eye |
| H16.222 | Keratoconjunctivitis sicca, not specified as sjogren's, left eye |
| H16.223 | Keratoconjunctivitis sicca, not specified as sjogren's, bilateral |
| H16.229 | Keratoconjunctivitis sicca, not specified as sjogren's, unspecified eye |
| Ocular irritation | |
| H57.8 | Other specified disorders of eye and adnexa |
| H57.89 | Other specified disorders of eye and adnexa |
| Ocular redness | |
| H57.8 | Other specified disorders of eye and adnexa |
| H57.89 | Other specified disorders of eye and adnexa |
| 0-9 | A-Z |
|---|---|
| H04.12 | Dry eye syndrome |
| H04.121 | Dry eye syndrome of right lacrimal gland |
| H04.122 | Dry eye syndrome of left lacrimal gland |
| H04.123 | Dry eye syndrome of bilateral lacrimal glands |
| H04.129 | Dry eye syndrome of unspecified lacrimal gland |
| H11.14 | Conjunctival xerosis, unspecified |
| H11.141 | Conjunctival xerosis, unspecified, right eye |
| H11.142 | Conjunctival xerosis, unspecified, left eye |
| H11.143 | Conjunctival xerosis, unspecified, bilateral |
| H11.149 | Conjunctival xerosis, unspecified, unspecified eye |
| H16.221 | Keratoconjunctivitis sicca, not specified as sjogren's, right eye |
| H16.222 | Keratoconjunctivitis sicca, not specified as sjogren's, left eye |
| H16.223 | Keratoconjunctivitis sicca, not specified as sjogren's, bilateral |
| H16.229 | Keratoconjunctivitis sicca, not specified as sjogren's, unspecified eye |
| H57.8 | Other specified disorders of eye and adnexa |
| H57.8 | Other specified disorders of eye and adnexa |
| H57.89 | Other specified disorders of eye and adnexa |
| H57.89 | Other specified disorders of eye and adnexa |
Formulary Reference Tool